# CROSCARMELLOSE SODIUM

URL: https://app.greenveil.ai/ingredients/ingredient_unii_m28_ol1_hh48
Categories: pharma
Identifier: chembl:CHEMBL2108932

> CROSCARMELLOSE SODIUM. Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 1 %w/v Assessed from 24 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 1 %w/v

## Regulatory status

- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 1 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 257 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 198 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 72 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 127 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 53 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 150 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 282 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 162 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 11.25 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 150 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 736 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 216 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 224 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 280 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 64 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 392 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 330 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 1875 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 184 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 10 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

_Assessed by Greenveil._